The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I-II trial of perioperative chemotherapy plus atezolizumab and tiragolumab in localized esophageal and gastroesophageal junction adenocarcinoma.
 
Mariela Blum Murphy
Consulting or Advisory Role - AstraZeneca; BeiGene
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Lianchun Xiao
No Relationships to Disclose
 
Xuemei Wang
No Relationships to Disclose
 
Matheus Sewastjanow-Silva
No Relationships to Disclose
 
Wayne Hofstetter
No Relationships to Disclose
 
Stephen Swisher
Honoraria - AstraZeneca; AstraZeneca (I); Conquer Cancer Foundation (I); HMP (I); Interline Therapeutics (I); Merck (I); MJH Healthcare Holdings, LLC (I); Virginia Commonwealth University (I)
Consulting or Advisory Role - Armada Health Care (I); AstraZeneca; AstraZeneca (I)
Research Funding - CairnSurgical (I); Lilly (I); Lumicell (I); OncoNano Inc (I)
Travel, Accommodations, Expenses - AstraZeneca (I)
 
Reza Mehran
No Relationships to Disclose
 
Kyle Mitchell
No Relationships to Disclose
 
Manoop Bhutani
No Relationships to Disclose
 
Brian Weston
No Relationships to Disclose
 
Emmanuel Coronel
No Relationships to Disclose
 
Jeannelyn Estrella
Stock and Other Ownership Interests - crispr therapeutics; GRAIL; Illumina; Masimo; Merck; Pfizer; Schrodinger
Honoraria - Ferronova
 
Rebecca Waters
No Relationships to Disclose
 
Dipen Maru
No Relationships to Disclose
 
Brian Witt
No Relationships to Disclose
 
Jenny Li
Consulting or Advisory Role - BeiGene
 
James Yao
No Relationships to Disclose
 
Jaffer Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Fresenius Kabi; Gilead Sciences; GRAIL; Lilly; Merck; Novartis; oncotherics; SERVIER; zymeworks
Consulting or Advisory Role - American Cancer Society; Amgen; Astellas Pharma; BeiGene; BeiGene; Bristol-Myers Squibb; Geneos; Gilead Sciences; Jazz Pharmaceuticals; Kyowa Kirin International; Merck; Novartis; SERVIER; Vaccinogen; Zymeworks
Research Funding - Amgen; Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; SERVIER (Inst); Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly